GenomicsbioRxivPreprint
ERBB2/HOXB13 co-amplification with interstitial deletion of BRCA1 defines a unique subset of breast cancers
Irene Rin Mitsiades, Maristela Lika Onozato, Anthony John Iafrate…·Esther Rheinbay
The paper identifies ERBB2/HOXB13 co-amplification with BRCA1 loss as a unique subset of breast cancers associated with shorter progression-free survival.
DOI 10.1101/2024.08.04.605361